Pancreatic Cancer Treatment and Management
PARP Inhibitors Shows Promise as Treatment for Pancreatic Cancer
Newsletter Signup | Join Community | Cancer Types
The latest genetic-genomic advances defining who should undergo screening for the early detection of pancreatic cancer.
Triplet immunotherapy - BL-8040 combination shows promising responses in metastatic pancreatic cancer.
Dr. Diane Simeone, M.D. Director of NYU-Langone Pancreatic Cancer Center answers your questions about pancreatic cancer.
Diagnosed with Pancreatic Cancer: 10 Tips on How to Get The Most From Your Doctor
Stage III pancreatic cancer is treated with surgery, chemotherapy, or participation is a clinical trial.
Treatment is with precision medicines & chemotherapy - genomic biomarker testing should be performed in all patients.
Pegylated human hyaluronidase (PEGPH20) fails to improve survival in pivotal clinical trial -development stoped.
I had IPMN and 30% of my pancreas resected Pathology of the cyst(post
Have pancreatic Ca. Whipple Procedure. On Xeloda & Gemzar. Afraid my…
Solid pseudopapillary neoplasm of the pancreas: Very rare and is info because someone asked:…
Real Time Genetic Sequencing Can Determine Pancreatic Cancer Treatment:…
Could there finally be a test to detect early stage pancreatic cancer?…
looking for promising clinical trials for pancreatic cancer that cant be treated by surgery?
I didnt know diabetes was associated with pancreatic cancer? Have others experienced this?…